New guidelines for conducting systematic reviews of animal and cell studies

A new publication in Nature Reviews Methods Primers provides essential guidance for conducting rigorous systematic reviews on studies with animals and cells.

AXT and CELLINK Form a Formidable Australian Bioprinting Partnership

3D bioprinting is experiencing rapid growth as the technology continues to evolve. This is certainly the case in Australia and AXT, who are already well

July 25, 2023

Formycon AG (von First Berlin Equity Research GmbH) – Biotech Investments

Original-Research: Formycon AG – from First Berlin Equity Research GmbH 19.08.2024 / 14:10 CET/CESTDissemination of a Research, transmitted by EQS News – a service of

August 20, 2024

Why CG Oncology will be the first test of 2024’s IPO waters

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian

January 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.